Keyphrases
Triple-negative Breast Cancer
100%
Transition State Inhibitors
100%
Methylthioadenosine Phosphorylase
80%
Methylthioadenosine
40%
Survival Rate
20%
Anticancer Therapeutics
20%
Anticancer Pathways
20%
Biochemical Pathways
20%
Body Accumulation
20%
Breast Cancer
20%
Technical Innovation
20%
Whole-body
20%
Targeted Therapeutics
20%
New Therapeutics
20%
Breast
20%
Once-daily
20%
New Targets
20%
Poor Prognosis
20%
National Institutes of Health
20%
Metastatic Relapse
20%
Oral Dosing
20%
Cancer Growth
20%
Oral Therapeutics
20%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
5' Methylthioadenosine Phosphorylase
80%
Malignant Neoplasm
40%
Oral
40%
Survival Rate
20%
Cancer Growth
20%
Breast Cancer
20%
Metabolite
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
5' Methylthioadenosine Phosphorylase
80%
Malignant Neoplasm
40%
Survival Rate
20%
Cancer Growth
20%
Breast Cancer
20%
Diseases
20%